These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 7518589

  • 21. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Milan DJ, Saul JP, Somberg JC, Molnar J.
    Cardiology; 2017; 136(1):52-60. PubMed ID: 27554842
    [Abstract] [Full Text] [Related]

  • 22. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN, Tang XC, Reda D, Singh BN.
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [Abstract] [Full Text] [Related]

  • 23. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R.
    Am J Cardiol; 1996 Aug 29; 78(4A):28-33. PubMed ID: 8780326
    [Abstract] [Full Text] [Related]

  • 24. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
    Qin D, Leef G, Alam MB, Rattan R, Munir MB, Patel D, Khattak F, Adelstein E, Jain SK, Saba S.
    J Cardiol; 2016 May 29; 67(5):471-6. PubMed ID: 26233885
    [Abstract] [Full Text] [Related]

  • 25. [Antiarrhythmic drugs in atrial fibrillation].
    Brembilla-Perrot B.
    Rev Prat; 2002 Jun 15; 52(12):1317-23. PubMed ID: 12187895
    [Abstract] [Full Text] [Related]

  • 26. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.
    N Engl J Med; 2000 Mar 30; 342(13):913-20. PubMed ID: 10738049
    [Abstract] [Full Text] [Related]

  • 27. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN, Mody FV, Lopez B, Sarma JS.
    Am J Cardiol; 1999 Nov 04; 84(9A):161R-173R. PubMed ID: 10568677
    [Abstract] [Full Text] [Related]

  • 28. Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.
    Tuinenburg AE, Van Gelder IC, Van Den Berg MP, Brügemann J, De Kam PJ, Crijns HJ.
    Heart; 1999 Oct 04; 82(4):486-93. PubMed ID: 10490566
    [Abstract] [Full Text] [Related]

  • 29. Sotalol: An important new antiarrhythmic.
    Anderson JL, Prystowsky EN.
    Am Heart J; 1999 Mar 04; 137(3):388-409. PubMed ID: 10047618
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological management of atrial fibrillation: an update.
    Hohnloser SH, Li YG, Bender B, Grönefeld G.
    J Cardiovasc Pharmacol Ther; 2000 Jan 04; 5(1):11-6. PubMed ID: 10687669
    [Abstract] [Full Text] [Related]

  • 31. The frequency analysis of signal-averaged ECG of P wave as predictor of efficacy of class III antiarrhythmic drugs to maintain sinus rhythm in recurrent idiopathic atrial fibrillation.
    Barbosa EC, Barbosa PR, Ginefra P, de Souza Bomfim A, Boghossian SH, da Rocha PJ, Filho FM.
    Ann Noninvasive Electrocardiol; 2001 Jan 04; 6(1):43-9. PubMed ID: 11174862
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D, Opolski G, Torbicki A.
    Med Sci Monit; 2001 Jan 04; 7(1):68-73. PubMed ID: 11208496
    [Abstract] [Full Text] [Related]

  • 33. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM.
    Card Electrophysiol Rev; 2003 Sep 04; 7(3):201-7. PubMed ID: 14739713
    [Abstract] [Full Text] [Related]

  • 34. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study.
    Kochiadakis GE, Igoumenidis NE, Marketou ME, Kaleboubas MD, Simantirakis EN, Vardas PE.
    Heart; 2000 Sep 04; 84(3):251-7. PubMed ID: 10956284
    [Abstract] [Full Text] [Related]

  • 35. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation.
    Dan GA, Gonţa A.
    Rom J Intern Med; 1997 Sep 04; 35(1-4):19-27. PubMed ID: 9562649
    [Abstract] [Full Text] [Related]

  • 36. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF.
    Eur Heart J; 2000 Jan 04; 21(1):66-73. PubMed ID: 10610746
    [Abstract] [Full Text] [Related]

  • 37. Beta-blockers for ventricular arrhythmias: have we underestimated their value?
    Campbell TJ.
    Aust N Z J Med; 1996 Oct 04; 26(5):689-96. PubMed ID: 8958366
    [No Abstract] [Full Text] [Related]

  • 38. [Atrial fibrillation: rhythm or rate control?].
    Le Heuzey JY, Saïd MA, Paziaud O.
    Rev Prat; 2002 Jun 15; 52(12):1335-8. PubMed ID: 12187898
    [Abstract] [Full Text] [Related]

  • 39. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.
    Health Technol Assess; 2010 Oct 15; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [Abstract] [Full Text] [Related]

  • 40. Comparison of class III antiarrhythmic drugs versus digoxin for the reversion of new-onset atrial fibrillation.
    Veloso HH.
    Ann Emerg Med; 2001 Jun 15; 37(6):735-6. PubMed ID: 11385352
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.